Business Description
Idorsia Ltd
ISIN : CH0363463438
Share Class Description:
IDRSF: Registered SharesTotal Employee Number:
232Description
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. The company is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide new therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. The company's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | -2.45 | |||||
Debt-to-Equity | -1.12 | |||||
Debt-to-EBITDA | -26.21 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -10.2 | |||||
Beneish M-Score | -3.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.4 | |||||
3-Year EBITDA Growth Rate | 63.6 | |||||
3-Year EPS without NRI Growth Rate | 45.4 | |||||
3-Year FCF Growth Rate | 46.2 | |||||
3-Year Book Growth Rate | -6.8 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 39.63 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 80.6 | |||||
9-Day RSI | 80.68 | |||||
14-Day RSI | 81.09 | |||||
3-1 Month Momentum % | 40.59 | |||||
6-1 Month Momentum % | 9.52 | |||||
12-1 Month Momentum % | 139.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.6 | |||||
Quick Ratio | 1.08 | |||||
Cash Ratio | 0.63 | |||||
Days Inventory | 1032.86 | |||||
Days Sales Outstanding | 65.92 | |||||
Days Payable | 285.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.2 | |||||
Shareholder Yield % | -6.48 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 87.89 | |||||
Operating Margin % | -55.08 | |||||
Net Margin % | -100.65 | |||||
EBITDA Margin % | -22.98 | |||||
FCF Margin % | -61.31 | |||||
OCF Margin % | -54.41 | |||||
ROA % | -46.82 | |||||
ROIC % | -26.86 | |||||
3-Year ROIIC % | -932.98 | |||||
ROC (Joel Greenblatt) % | -33.22 | |||||
ROCE % | -27.49 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 7.12 | |||||
EV-to-EBIT | -41.21 | |||||
EV-to-EBITDA | -54.38 | |||||
EV-to-Revenue | 13.12 | |||||
EV-to-Forward-Revenue | 13.02 | |||||
EV-to-FCF | -21.4 | |||||
Price-to-GF-Value | 2.19 | |||||
Earnings Yield (Greenblatt) % | -2.43 | |||||
FCF Yield % | -8.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IDRSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Idorsia Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 274.046 | ||
| EPS (TTM) ($) | -1.294 | ||
| Beta | 3.2126 | ||
| 3-Year Sharpe Ratio | 0.32 | ||
| 3-Year Sortino Ratio | 0.57 | ||
| Volatility % | 77.33 | ||
| 14-Day RSI | 81.09 | ||
| 14-Day ATR ($) | 0.120953 | ||
| 20-Day SMA ($) | 6.5325 | ||
| 12-1 Month Momentum % | 139.58 | ||
| 52-Week Range ($) | 2.4 - 7.7 | ||
| Shares Outstanding (Mil) | 255.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Idorsia Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Idorsia Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Idorsia Ltd Frequently Asked Questions
What is Idorsia Ltd(IDRSF)'s stock price today?
The current price of IDRSF is $7.40. The 52 week high of IDRSF is $7.70 and 52 week low is $2.40.
When is next earnings date of Idorsia Ltd(IDRSF)?
The next earnings date of Idorsia Ltd(IDRSF) is .
Does Idorsia Ltd(IDRSF) pay dividends? If so, how much?
Idorsia Ltd(IDRSF) does not pay dividend.
Guru Commentaries on OTCPK:IDRSF
No articles.
Press Release
Articles on Idorsia Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers